K2 Biolabs, Inc. — Form D

K2 Biolabs, Inc. of Houston, TX, a company, filed a Form D exempt-offering notice with the SEC on 2021-03-12. The offering totals $5.5M, of which $5.5M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2021-03-12
• Form: D
• Accession: 0001848448-21-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $5.5M
• Amount sold: $5.5M
• Minimum investment: $25K
• Investors: 40
• Date of first sale: 2021-03-01
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-392132

Issuer

• Name: K2 Biolabs, Inc.
• CIK: 0001848448
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2021
• Address: 2710 Reed Road , Ste. 160, Houston, TX, 77051
• Phone: (347) 752-3124

Officers, directors & promoters (10)

Other filings by this issuer (1)

More

• CIK 1848448 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search